Chief Legal Officer and Corporate Secretary · Context Therapeutics Inc. (CNTX)

Alex Levit

FY2025 is the first fiscal year CompBrief holds for Alex Levit as a named executive officer of Context Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$816,671

Compensation figures as of the proxy filed April 28, 2026 (DEF 14A).

Alex Levit compensation by year

Context Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Context Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$397,807
Bonus$8,000
Stock awards$0
Option awards$240,364
Non-equity incentive$160,000
Pension and deferred compensation$0
All other$10,500
Total$816,671

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Context Therapeutics Inc. DEF 14A filed April 28, 2026, accession 0001628280-26-027928, and prior-year filings. Open the filing on EDGAR.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option4,495—$1.79
Option349,900—$0.81
Option86,352—$1.07
Option44,189—$0.84

Per the Outstanding Equity Awards at Fiscal Year-End table in Context Therapeutics Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Context Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Martin LehrChief Executive Officer$1,465,430
Jennifer Minai-AzaryChief Financial Officer and Treasurer$866,139
Alex Levit · this pageChief Legal Officer and Corporate Secretary$816,671

The full Context Therapeutics compensation record

free company brief

This page is one person within Context Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Context Therapeutics's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Context Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy